Skip to content

Author

H. G. van der Poel

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Reproducibility and diagnostic performance of ADC for assessing response to neoadjuvant immunotherapy in muscle-invasive bladder cancer: a multi-ROI comparison analysis from the phase-Ib NABUCCO trial

MRI is increasingly used to assess treatment response in muscle-invasive bladder cancer (MIBC), but only qualitatively. This study evaluates the reproducibility and predictive value of quantitative apparent diffusion coefficient (ADC), thought to be a non-invasive surrogate for tumor cell density, in patients with MIBC...

J. Greidanus, Carlotta Bernabei, K. Chupetvloska et al. · 0 citations
Aug 2026

Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial.

The prospective TRACE-I trial demonstrated that robot-assisted 99mtechnetium-PSMA-Investigation & Surgery-RGS using a DROP-IN gamma probe is feasible and safe in recurrent prostate cancer (PCa), but careful patient selection is essential.

L. Zuur, H. D. de Barros, V. A. Ottens et al. · 0 citations
Review Open access Sep 2026

Molecular imaging tracers targeting c-MET: a systematic review of preclinical evidence and clinical translation.

INTRODUCTION The mesenchymal-epithelial transition factor (c-MET) is an emerging target for molecular imaging owing to its widespread overexpression across multiple cancer types. This systematic review evaluated radioactive and fluorescent c-MET-targeting tracers in preclinical and clinical studies, focussing on their...

R. Verdijk, Stevie M. van der Mierde, Nataliia Berehova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.